AlbuSorb:<\/strong><\/p>\nCerebrospinal Fluid Gwenael Pottiez, Pawel Ciborowski. Proteomic Profiling of Cerebrospinal Fluid Expression Profiling In Neuroscience Neuromethods.2012;64:245-270 Synovial fluid Happonen KE, F\u00fcrst CM, Saxne T et al.<\/p>\n
PRELP protein inhibits the formation of the complement membrane attack complex.Journal of Biological Chemistry.2012;287(11):8092-100 Serum Holmberg R, Refai E, H\u00f6\u00f6g A.Lowering apolipoprotein CIII delays onset of type 1 diabetes. Proceedings of the National Academy of Sciences.2011;108(26):10685-9. Tang MX, Ogawa K, Asamoto M.<\/p>\n
Effects of Nobiletin on PhIP-Induced Prostate and Colon Carcinogenesis in F344 Rats Nutrition and Cancer.2011;63(2):227-33 Holmberg, Rebecka Apolipoprotein CIII and Ljungan virus in diabetes 2010. Doctoral Thesis Lu Q, Zheng X, McIntosh T<\/p>\n
Development of different analysis platforms with LC-MS for pharmacokinetic studies of protein drugs. Analytical Chemistry.2009;81(21):8715-23 Urine Zubiri, Irene, et al.<\/p>\n
Diabetic nephropathy induces changes in the proteome of human urinary exosomes as revealed by label-free comparative analysis. Journal of Proteomics (2013). Patent Berggren, Per Olaf, Yang, Shao-Nian. 2012. Methods For Treating And\/Or Limiting Development Of Diabetes.U.S. Patent 20120328630 Kind Code: A1, filed June 25, 2012, and issued December 27,<\/p>\n
AlbuVoid:<\/strong><\/p>\nSun, Zhenyu, Xiaofeng Chen, Gan Wang, Liang Li, Guofeng Fu, Matthew Kuruc, and Xing Wang. “Identification of functional metabolic biomarkers from lung cancer patient serum using PEP technology.” Biomarker Research 4, no. 1 (2016): 1.<\/p>\n
Haiyan Zheng; Caifeng Zhao; Swapan Roy; Devjit Roy MD; Amenah Soherwardy; Ravish Amin; Matthew Kuruc. Application Report – The Comparison of the Serum Proteome in Individuals with Cancers versus those without Cancer, and its application to Wellness<\/p>\n
Dr.Swapan Roy; Amenah Soherwardy; Ravish Amin; Matthew Kuruc.Monmouth Junction, NJ – Application Report. AlbuSorb\u2122 Product Extension combines Albumin and Immunoglobulin Depletion in a Consumable Format<\/p>\n
Xing Wang, Michael Davies, Swapan Roy and Matthew Kuruc. Bead Based Proteome Enrichment Enhances Features of the Protein Elution Plate (PEP) for Functional Proteomic Profiling . Proteomes 2015, 3(4), 454-466 . doi: 10.3390\/proteomes3040454<\/p>\n
Haiyan Zheng, Caifeng Zhao, Meiqian Qian, Swapan Roy, Absari Arpa, Amenah Soherwardy and Matthew Kuruc. AlbuVoid\u2122 Coupled to On-Bead Digestion – Tackling the Challenges of Serum Proteomics. J Proteomics Bioinform 2015, 8:9.
\nKuruc Matt, Dr.Roy. Application Report – AlbuVoid\u2122 LC-MS On-Bead \u2013 Differential Expression of Cancer Sera Proteins Using Quantitative (iTRAQ) Proteomics<\/p>\n
Grubbs, J. K., et al. ” Investigation of the efficacy of albumin removal procedures on porcine serum proteome profile1.” (2015).<\/p>\n
Serum Profiling Making Mark on Predictive Medicine Vicki Glaser.Genetic Engineering & Biotechnology News. 2011;31(7):1-55.<\/p>\n
AlbuVoid\u2122 with Plasma:<\/strong><\/p>\nEspes, Daniel, Joey Lau, and Per-Ola Carlsson. ” AIncreased circulating levels of betatrophin in individuals with long-standing type 1 diabetes.” Diabetologia(2013): 1-4.<\/p>\n
Patent – Secretome Sample Preparation<\/p>\n
Narain, Niven Rajin, and Paula Patricia Narain. ” COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF PERVASIVE DEVELOPMENTAL DISORDER.” U.S. Patent No. 20,150,023,949. 22 Jan. 2015.<\/p>\n
Narain, Niven Rajin, Rangaprasad Sarangarajan, and Vivek K. Vishnudas. ” INTERROGATORY CELL-BASED ASSAYS AND USES THEREOF.” U.S. Patent No. 20,120,258,874. 11 Oct. 2012.<\/p>\n
<\/p>\n
<\/p>\n","protected":false},"excerpt":{"rendered":"
Biotech Support Group bring you\u00a0two alternate strategies\u00a0for albumin removal from sample preparations: AlbuSorb – an albumin binding strategy AlbuVoid – an albumin voiding strategy plus Albutrial, a combined trial kit including\u00a01 gm of AlbuSorb\u2122 and 5 Preps of AlbuVoid\u2122 with<\/p>\n","protected":false},"author":13,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[357],"class_list":["post-1576","post","type-post","status-publish","format-standard","hentry","category-general-information","tag-biotech-support-group"],"_links":{"self":[{"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/posts\/1576","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/comments?post=1576"}],"version-history":[{"count":7,"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/posts\/1576\/revisions"}],"predecessor-version":[{"id":2168,"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/posts\/1576\/revisions\/2168"}],"wp:attachment":[{"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/media?parent=1576"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/categories?post=1576"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/tags?post=1576"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
![\"Albuvoid\"](\"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-content\/uploads\/Albuvoid.png\")
<\/a><\/p>\n